Cardlytics (CDLX) Tops Q3 EPS by 66c

Cardlytics (NASDAQ: CDLX) reported Q3 EPS of $0.01, $0.66 better than the analyst estimate of ($0.65). Revenue for the quarter came in at $79 million versus the consensus estimate of $80.01 million.

For earnings history and earnings-related data on Cardlytics (CDLX) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Credo Technology pops 3.5% as Evercore initiates with monster $325 price target
• Hermès can regain momentum despite China weakness, Jefferies says